TREATMENT OF PH+ CML IN EARLY CHRONIC PHASE WITH SEQUENTIAL ADMINISTRATION OF NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY: A GIMEMA PHASE 2 MULTICENTRIC STUDY

MLA

Castagnetti, F., et al. Treatment of Ph+ Cml in Early Chronic Phase with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: A Gimema Phase 2 Multicentric Study. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..a54e0f44406c65d19ec6c7199c60483d&authtype=sso&custid=ns315887.

APA

Castagnetti, F., Rosti, G., Breccia, M., Gozzini, A., Stagno, F., Rege Cambrin, G., Pierri, I., Luciano, L., Abruzzese, E., Martino, B., Capucci, A., Bocchia, M., Cavazzini, F., Tiribelli, M., Gugliotta, G., Palandri, F., Durante, S., Soverini, S., Testoni, N., … Baccarani, M. (2012). Treatment of Ph+ Cml in Early Chronic Phase with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: A Gimema Phase 2 Multicentric Study.

Chicago

Castagnetti, F, G Rosti, M Breccia, A Gozzini, F Stagno, G Rege Cambrin, I Pierri, et al. 2012. “Treatment of Ph+ Cml in Early Chronic Phase with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: A Gimema Phase 2 Multicentric Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3686..a54e0f44406c65d19ec6c7199c60483d&authtype=sso&custid=ns315887.